Cargando…

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

BACKGROUND: Gliomas are one of the most common primary tumors of the central nervous system, and have an unfavorable prognosis. SLC39A1 is a zinc ion transport protein which inhibits the progression of prostate cancer. By studying the role and mechanism of SLC39A1 in the progression of gliomas, perh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Peng, Zhang, Jingjing, He, Shuai, Xiao, Boan, Peng, Xiaobin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694905/ https://www.ncbi.nlm.nih.gov/pubmed/33292262 http://dx.doi.org/10.1186/s12935-020-01675-0

Ejemplares similares

Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression
por: Zhang, Yunwen, et al.
Publicado: (2023)

SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways
por: Wang, Xizhao, et al.
Publicado: (2019)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway
por: Liu, Zelin, et al.
Publicado: (2022)

m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas
por: Chai, Rui-Chao, et al.
Publicado: (2019)

Histone methyltransferase SUV39H2 regulates cell growth and chemosensitivity in glioma via regulation of hedgehog signaling
por: Wang, Ran, et al.
Publicado: (2019)

ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target
por: Bikeye, Sandra-Nadia Ngwabyt, et al.
Publicado: (2010)

Prognostic role of METTL1 in glioma
por: Li, Lun, et al.
Publicado: (2021)

SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer
por: Dai, Wumin, et al.
Publicado: (2021)

LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2021)

Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells
por: Yuan, Zhaohu, et al.
Publicado: (2017)

Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway
por: Ge, Yiqin, et al.
Publicado: (2016)

CircRFX3 contributes to glioma progression through the circRFX3-miR-1179/miR-1229-VASP axis
por: Li, Hongli, et al.
Publicado: (2021)

Contribution of nestin positive esophageal squamous cancer cells on malignant proliferation, apoptosis, and poor prognosis
por: Zhong, Beilong, et al.
Publicado: (2014)

FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
por: Chen, Jinzhang, et al.
Publicado: (2020)

CircRNA NALCN acts as an miR-493-3p sponge to regulate PTEN expression and inhibit glioma progression
por: Liu, Yi, et al.
Publicado: (2021)

Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5
por: Chang, Zhiwei, et al.
Publicado: (2021)

Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma
por: Calogero, Antonella, et al.
Publicado: (2004)

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression
por: Ma, Xiaowu, et al.
Publicado: (2022)

Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy
por: Xu, Houshi, et al.
Publicado: (2021)

SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer
por: Du, Pengcheng, et al.
Publicado: (2019)

SLC39A7 promotes malignant behaviors in glioma via the TNF-α-mediated NF-κB signaling pathway
por: Chen, Lian, et al.
Publicado: (2021)

Role of SLC39A6 in the development and progression of liver cancer
por: Wan, Zhen, et al.
Publicado: (2022)

Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells
por: Honma, Kimi, et al.
Publicado: (2007)

Identification of 3 subpopulations of tumor-infiltrating immune cells for malignant transformation of low-grade glioma
por: Lu, Jiacheng, et al.
Publicado: (2019)

SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer
por: Yao, Xingxing, et al.
Publicado: (2020)

USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A(165b) alternative splicing via regulating SRSF1 and SRPK1
por: Pan, Xiu-wu, et al.
Publicado: (2021)

Identifying SLC27A5 as a potential prognostic marker of hepatocellular carcinoma by weighted gene co-expression network analysis and in vitro assays
por: Zhang, Fan, et al.
Publicado: (2021)

OIP5-AS1 contributes to the development in endometrial carcinoma cells by targeting miR-152-3p to up-regulate SLC7A5
por: Liang, Minglin, et al.
Publicado: (2021)

Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma
por: Chai, Rui-Chao, et al.
Publicado: (2019)

Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer
por: Zhang, Meng, et al.
Publicado: (2020)

MiR-4310 induced by SP1 targets PTEN to promote glioma progression
por: Wu, Zhiyong, et al.
Publicado: (2020)

Antiproliferative and apoptosis-inducing activity of schisandrin B against human glioma cells
por: Li, Qun, et al.
Publicado: (2015)

Influence on the behavior of lung cancer H1299 cells by silencing SLC35F2 expression
por: Li, Xiao, et al.
Publicado: (2013)

Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway
por: Li, Huixia, et al.
Publicado: (2020)

Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma
por: Luo, Haitao, et al.
Publicado: (2021)

A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer
por: Liu, Lei, et al.
Publicado: (2021)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

SLC39A4 as a Novel Prognosis Marker Promotes Tumor Progression in Esophageal Squamous Cell Carcinoma
por: Xia, Chenmei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ev7qg6ofi4q6m1evrsh84cg4l5